ConductScience.org, home

Trial · NCT07905729

Comparative Effects of tDCS and tACS on Pain, Dexterity, and Strength in Diabetic Peripheral Neuropathy

NCT07905729, Not applicable, Active not recruiting, University of Management and Technology Lahore

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Comparative Effects of tDCS and tACS on Pain, Dexterity, and Strength in Diabetic Peripheral Neuropathy. Trials, record NCT07905729. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905729

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Comparative Effects of tDCS and tACS on Pain, Dexterity, and Strength in Diabetic Peripheral Neuropathy
NCT number
NCT07905729
Status
Active not recruiting
Phases
Not applicable
Enrollment
46 participants, actual
Lead sponsor
University of Management and Technology Lahore
Conditions
Diabetic Peripheral Neuropathy (DPN)
Interventions
Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS)
First posted
2026-10-29
Last updated
2026-11-03

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPain by McGill Pain Questionnaire-2at baseline and after 4th week
The MPQ-2 is a self-report questionnaire designed to evaluate different dimensions of pain, including continuous, intermittent, neuropathic, and affective pain descriptors. The questionnaire consists of 22 pain descriptors, each rated on an 11-point numerical scale ranging from 0 (none) to 10 (worst possible).
PrimaryIsometric Muscle Strength by digital force gauge SF-500at baseline and after 4th week
It will measure muscle groups such as shoulder flexors, extensors, abductors, adductors, elbow flexors and extensors, wrist flexors and extensors in Kg. Before the test, a standard instruction of "push as hard as you can" will give, and during the test, the patients will be encourage to apply maximal effort. Maximal strength will exerted for 3 to 5 seconds, at which point the examiner instructed the person to relax. Maximal isometric muscle strength will recorded for all measured upper-extremity muscle groups
PrimaryManual Dexterity by Wooden 9 hole peg testat baseline and after 4th week
The NHPT consists of a rectangular base and 9 pegs (7 mm in diameter, 32 mm in length). The base is divided into two parts; the container is located where the pegs will be housed in one, while a pegboard composed of 9 holes (10 mm in diameter, 15 mm deep) in which each of the pegs will be inserted is in the other. The pegboard will centered in front of the subject with the container side on the same side as the hand being tested. The dominant hand will tested first. Subjects completed one practice trial followed by the actual timed test for each hand

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
24466511BACKGROUNDPubMed
36467691BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07905729

GET https://conductscience.org/api/trials/v1/NCT07905729/registered